Revvity Inc (RVTY) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Revvity Inc  (NYSE: RVTY)


Revvity Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



RVTY Gross Profit Margin (Oct 04 2026)
Q3
(Jul 05 2026)
Q2
(Apr 05 2026)
Q1
(Dec 28 2025)
Q4
(Sep 28 2025)
Q3
Y / Y Revenue Change 4.29 %
Seq. Revenue Change -0.11 %
Revenue In Millions $728.90
Gross Profit Margin 57.43 %
Gross Profit Margin Total Ranking # 1562
Gross Profit In Millions $418.58
Y / Y Gross Profit Change 11.74 %
Seq. Gross Profit Change 0.41 %


Commenting Third Quarter 2026 Gross Profit Margin
Revvity Inc achieved Gross Profit of $419 millions compare to Gross Loss of $416.87 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -0.11 % Revvity Inc managed to reduce Cost of Sales and increase Gross Profit by 0.41 % to $419 millions. Gross Profit Margin grew to 57.43 %, below company average Gross Profit Margin.


Observing third quarter 2026 results within Laboratory Analytical Instruments industry 7 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 796 to 1562.
Learn about Gross Margin
RVTY's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 286
Overall # 1550

Gross Profit Margin Statistics
High Average Low
86.75 % 60.2 % 33.31 %
(Mar 29 2015)   (Dec 31 2023)




Other Gross Profit Margin Profitability Ratios
RVTY's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
RVTY's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for RVTY's Competitors
Gross Profit Margin Profit Margin for Revvity Inc's Suppliers
Gross Profit Margin Profit Margin for RVTY's Customers

You may also want to know
RVTY's Annual Growth Rates RVTY's Profitability Ratios RVTY's Asset Turnover Ratio RVTY's Dividend Growth
RVTY's Roe RVTY's Valuation Ratios RVTY's Financial Strength Ratios RVTY's Gross Profit Growth
RVTY's Roa RVTY's Inventory Turnover Ratio RVTY's Growth Rates RVTY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Oct 04 2026, within Laboratory Analytical Instruments Industry Gross Profit MarginOct 04 2026 MRQ Gross ProfitOct 04 2026 MRQ Revenue
Nautilus Biotechnology Inc   89.74 %$ 0.210  Millions$ 0.234  Millions
10x Genomics Inc   74.95 %$ 112.927  Millions$ 150.667  Millions
Illumina Inc   73.52 %$ 830.000  Millions$ 1,129.000  Millions
Alamar Biosciences Inc   61.54 %$ 20.644  Millions$ 33.545  Millions
Mettler toledo International Inc   59.79 %$ 654.224  Millions$ 1,094.294  Millions
Cytek Biosciences Inc   58.63 %$ 31.206  Millions$ 53.229  Millions
Revvity Inc  57.43 %$ 418.579  Millions$ 728.899  Millions
Standard Biotools Inc   55.86 %$ 10.828  Millions$ 19.385  Millions
Harvard Bioscience Inc   55.45 %$ 12.307  Millions$ 22.196  Millions
Bio rad Laboratories Inc   50.06 %$ 328.600  Millions$ 656.400  Millions
Bruker Corporation  49.12 %$ 429.300  Millions$ 874.000  Millions
Bionano Genomics Inc   47.72 %$ 3.949  Millions$ 8.276  Millions
Seer Inc   47.20 %$ 1.879  Millions$ 3.981  Millions
Precipio inc   46.08 %$ 3.378  Millions$ 7.331  Millions
Quanterix Corporation  38.60 %$ 13.500  Millions$ 34.974  Millions
Pacific Biosciences Of California Inc   33.21 %$ 13.470  Millions$ 40.564  Millions
Avantor Inc   31.49 %$ 534.800  Millions$ 1,698.300  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.